Harmony Biosciences Holdings, Inc. (HRMY)
USD 30.32
(1.54%)
USD 30.32
(1.54%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 193.56 Million USD | 1.0% |
| 2022 | 191.64 Million USD | -0.18% |
| 2021 | 191.98 Million USD | -1.17% |
| 2020 | 194.25 Million USD | 98.32% |
| 2019 | 97.94 Million USD | -69.79% |
| 2018 | 324.2 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 193.06 Million USD | -0.26% |
| 2024 Q3 | 182.84 Million USD | -16.61% |
| 2024 Q2 | 219.26 Million USD | 13.57% |
| 2023 Q3 | 197.13 Million USD | 2.95% |
| 2023 Q2 | 191.48 Million USD | -0.04% |
| 2023 FY | 193.56 Million USD | 1.0% |
| 2023 Q1 | 191.56 Million USD | -0.04% |
| 2023 Q4 | 193.56 Million USD | -1.81% |
| 2022 Q2 | 191.8 Million USD | -0.05% |
| 2022 Q1 | 191.89 Million USD | -0.05% |
| 2022 FY | 191.64 Million USD | -0.18% |
| 2022 Q4 | 191.64 Million USD | -0.04% |
| 2022 Q3 | 191.72 Million USD | -0.04% |
| 2021 Q1 | 194.91 Million USD | 0.34% |
| 2021 FY | 191.98 Million USD | -1.17% |
| 2021 Q4 | 191.98 Million USD | -0.04% |
| 2021 Q3 | 192.06 Million USD | -1.81% |
| 2021 Q2 | 195.61 Million USD | 0.36% |
| 2020 Q2 | 192.51 Million USD | 0.18% |
| 2020 Q3 | 192.85 Million USD | 0.18% |
| 2020 Q4 | 194.25 Million USD | 0.72% |
| 2020 FY | 194.25 Million USD | 98.32% |
| 2020 Q1 | 192.17 Million USD | 96.21% |
| 2019 Q4 | 97.94 Million USD | 0.0% |
| 2019 FY | 97.94 Million USD | -69.79% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 324.2 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -136214.085% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2427.83% |
| XOMA Corporation | 124.45 Million USD | -55.537% |
| Mesoblast Limited | 118.92 Million USD | -62.766% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 15.544% |
| Aptorum Group Limited | 3.36 Million USD | -5656.786% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -14798.677% |
| HilleVax, Inc. | 51.19 Million USD | -278.11% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -672.965% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -826.852% |
| Precision BioSciences, Inc. | 31.26 Million USD | -519.055% |
| Dyadic International, Inc. | 136.92 Thousand USD | -141262.312% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -122410.127% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -6639.763% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -3448.414% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -90351.402% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -3439.331% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 15.633% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1458.001% |
| IGM Biosciences, Inc. | 40.5 Million USD | -377.87% |
| Opthea Limited | 200.62 Million USD | 3.52% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -273.86% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -3484.556% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1872.547% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -3039.757% |
| NextCure, Inc. | 6.6 Million USD | -2830.598% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -31019.786% |
| Ovid Therapeutics Inc. | 46 Million USD | -320.78% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -811.371% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -540.608% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -211.826% |
| Senti Biosciences, Inc. | 37.66 Million USD | -413.901% |
| Apollomics, Inc. | 4.66 Million USD | -4052.886% |
| PureTech Health plc | 25.51 Million USD | -658.725% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -60769.811% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1391.723% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -128.601% |
| ChromaDex Corporation | 3.27 Million USD | -5806.805% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -85.796% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -407.994% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -84.744% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -86.955% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -90.924% |
| Fortress Biotech, Inc. | 88.59 Million USD | -118.492% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -206.435% |
| Celcuity Inc. | 37.44 Million USD | -416.916% |
| ContextLogic Inc. | 6 Million USD | -3126.1% |
| GH Research PLC | 343 Thousand USD | -56333.236% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -2851.151% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -523051.351% |
| ImmuCell Corporation | 11.96 Million USD | -1517.187% |
| Amarin Corporation plc | 8.73 Million USD | -2115.474% |
| TG Therapeutics, Inc. | 110.79 Million USD | -74.706% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -232.125% |
| Acelyrin, Inc. | 1.19 Million USD | -16111.558% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -584.971% |
| Novavax, Inc. | 280.63 Million USD | 31.026% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -39.226% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.661% |
| AnaptysBio, Inc. | 17.81 Million USD | -986.595% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3486.548% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1356.917% |
| AbCellera Biologics Inc. | 77.38 Million USD | -150.15% |
| CorMedix Inc. | 667.63 Thousand USD | -28892.918% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1666.919% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 92.839% |
| Aptose Biosciences Inc. | 1 Million USD | -19068.632% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2236106.1% |
| Soligenix, Inc. | 3.49 Million USD | -5439.065% |
| Century Therapeutics, Inc. | 48.17 Million USD | -301.831% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -68.068% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -42860.155% |
| Kura Oncology, Inc. | 17.2 Million USD | -1025.384% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -2702.867% |
| Ardelyx, Inc. | 55.98 Million USD | -245.765% |
| Ainos, Inc. | 5.96 Million USD | -3145.815% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -109.412% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -8903.07% |
| Prothena Corporation plc | 11.83 Million USD | -1535.539% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1285.187% |
| Autolus Therapeutics plc | 52.96 Million USD | -265.446% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -667.054% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -362.601% |
| Celularity Inc. | 65.41 Million USD | -195.896% |
| Rallybio Corporation | 392 Thousand USD | -49279.082% |
| GRI Bio, Inc. | 14 Thousand USD | -1382514.286% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | 42.78% |
| INmune Bio, Inc. | 10.43 Million USD | -1754.613% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -7.759% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3176.859% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -236880.901% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -23310.22% |
| Humacyte, Inc. | 58.1 Million USD | -233.126% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -234.473% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 59.744% |
| Immunocore Holdings plc | 84.03 Million USD | -130.348% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -10346.087% |
| Verastem, Inc. | 41.55 Million USD | -365.784% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1602.128% |
| Histogen Inc. | 4.62 Million USD | -4087.927% |
| Surrozen, Inc. | 3.37 Million USD | -5628.5% |
| Blueprint Medicines Corporation | 774.12 Million USD | 74.995% |
| Organovo Holdings, Inc. | 1.39 Million USD | -13785.653% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -7661.267% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -333634.483% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -128.834% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -92506.449% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -3757.433% |
| Summit Therapeutics Inc. | 106.09 Million USD | -82.439% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -75.398% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -119151.834% |
| Turnstone Biologics Corp. | 3.21 Million USD | -5922.589% |
| Pulmatrix, Inc. | 8.75 Million USD | -2110.667% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -78266.802% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -98.312% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1297.588% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -67.813% |
| Cytokinetics, Incorporated | 755.77 Million USD | 74.388% |
| Exelixis, Inc. | 189.94 Million USD | -1.907% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -532.279% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -74.497% |
| Evogene Ltd. | 1.13 Million USD | -16909.315% |
| Replimune Group, Inc. | 75.86 Million USD | -155.132% |
| PDS Biotechnology Corporation | 23.85 Million USD | -711.542% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -350785.525% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -6847.81% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -240869.525% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -395983.487% |
| BioLineRx Ltd. | 11.59 Million USD | -1569.968% |
| Avid Bioservices, Inc. | 207.83 Million USD | 6.865% |
| Insmed Incorporated | 1.2 Billion USD | 83.923% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -9030.472% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -322.882% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -297693.846% |
| MediWound Ltd. | 6.71 Million USD | -2784.309% |
| MiMedx Group, Inc. | 48.09 Million USD | -302.432% |
| OmniAb, Inc. | 25.56 Million USD | -657.271% |
| Alector, Inc. | 38.91 Million USD | -397.369% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 9.522% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 53.361% |
| Mereo BioPharma Group plc | 5.95 Million USD | -3152.117% |
| Zai Lab Limited | 15.15 Million USD | -1177.579% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 59.542% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -11738.899% |
| Aura Biosciences, Inc. | 19.55 Million USD | -889.753% |
| Immunic, Inc. | 1.33 Million USD | -14410.195% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -606.059% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -510.003% |
| Veracyte, Inc. | 12.63 Million USD | -1432.589% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 69.983% |
| FibroGen, Inc. | 170.45 Million USD | -13.558% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2031.549% |
| Allakos Inc. | 41.46 Million USD | -366.818% |
| scPharmaceuticals Inc. | 40.26 Million USD | -380.682% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1688.8% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -128089.404% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -11747.986% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -94826.708% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -4468.468% |
| Precigen, Inc. | 7.09 Million USD | -2627.434% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 88.464% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -2545.428% |
| Incyte Corporation | 38.28 Million USD | -405.566% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -64268.802% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -348.412% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1637.888% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -6847.81% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 18.885% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -643.255% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -55363.037% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -620.085% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -329.45% |
| Agenus Inc. | 350.24 Million USD | 44.734% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -180987.276% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -13541.015% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -327.903% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -348.391% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -301.348% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -117951.803% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 77.193% |
| UroGen Pharma Ltd. | 100.21 Million USD | -93.153% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -18740.41% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -5.919% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1363617.064% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -63364.262% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -49278.83% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -2731.982% |
| Chimerix, Inc. | 2.14 Million USD | -8928.265% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -19793.731% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -444.409% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -111999.749% |
| Pluri Inc. | 29.61 Million USD | -553.674% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1217.224% |
| MeiraGTx Holdings plc | 89.26 Million USD | -116.847% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -906532.319% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -3868.956% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -213.122% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -85.95% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -2698.41% |
| NLS Pharmaceutics AG | 1.63 Million USD | -11747.986% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -513.56% |
| Nutriband Inc. | 241.28 Thousand USD | -80122.973% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -3440.626% |
| Vor Biopharma Inc. | 35.66 Million USD | -442.81% |
| Roivant Sciences Ltd. | 499.74 Million USD | 61.267% |
| ProKidney Corp. | 4.41 Million USD | -4286.268% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -15688.418% |
| Daré Bioscience, Inc. | 5.31 Million USD | -3539.728% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 88.874% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -34159.469% |
| Bicycle Therapeutics plc | 44.95 Million USD | -330.568% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -397.343% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -169.564% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -120.101% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1074.836% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -7797.443% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -28576.444% |
| MediciNova, Inc. | 215.92 Thousand USD | -89544.6% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -7658.156% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -15249.857% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -16864.592% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -3.86% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1780.012% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -246.526% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -5291.811% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2012.935% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1219.378% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1479.099% |
| bluebird bio, Inc. | 330.32 Million USD | 41.402% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1447.785% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -11813.851% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 82.929% |
| BioAtla, Inc. | 2.46 Million USD | -7768.537% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -103.494% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -3390.191% |
| DBV Technologies S.A. | 14.38 Million USD | -1245.984% |
| Fortress Biotech, Inc. | 88.59 Million USD | -118.492% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1864.738% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -922.374% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1182.319% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -819.641% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -59186.417% |
| Galecto, Inc. | 249 Thousand USD | -77637.349% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -11762.661% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 87.089% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -82.499% |
| Entera Bio Ltd. | 390 Thousand USD | -49532.308% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 52.18% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -3018.009% |
| Xencor, Inc. | 83.43 Million USD | -131.999% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -11373.977% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -4099.74% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -15711.296% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -1958.337% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -117951.803% |
| Portage Biotech Inc. | 47 Thousand USD | -411742.553% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -15249.857% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -7908.523% |
| OncoCyte Corporation | 2.86 Million USD | -6646.811% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -128469.151% |
| Purple Biotech Ltd. | 351 Thousand USD | -55047.009% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -6027.445% |
| Onconetix, Inc. | 9.88 Million USD | -1858.026% |
| MacroGenics, Inc. | 33.97 Million USD | -469.798% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -9416.524% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -3600.363% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -1319.834% |
| Aditxt, Inc. | 18.21 Million USD | -962.499% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -623.936% |
| Curis, Inc. | 2.79 Million USD | -6827.917% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -8960.174% |
| Adagene Inc. | 22.3 Million USD | -767.742% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1056.93% |
| BeiGene, Ltd. | 930.18 Million USD | 79.191% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 7.888% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -23844.275% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 68.318% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -254592.105% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -7636.451% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -136.008% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 5.998% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -4068.088% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 92.784% |
| ADMA Biologics, Inc. | 141.41 Million USD | -36.875% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -219.527% |
| Clene Inc. | 32.16 Million USD | -501.866% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -7514.713% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -926.712% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -8718.497% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -281.998% |
| Adicet Bio, Inc. | 20.92 Million USD | -825.091% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -0.194% |
| Absci Corporation | 15.95 Million USD | -1113.048% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1164.889% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -853.856% |
| Surrozen, Inc. | 3.37 Million USD | -5628.5% |
| Generation Bio Co. | 97.89 Million USD | -97.73% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -58734.65% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -604.261% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -665.143% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -688.713% |
| Invivyd, Inc. | 2.16 Million USD | -8840.693% |
| Cingulate Inc. | 3.13 Million USD | -6074.159% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -262.036% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -5493113.158% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -38543.41% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -3392.08% |
| Jaguar Health, Inc. | 35.86 Million USD | -439.782% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -307147.619% |
| 2seventy bio, Inc. | 256.67 Million USD | 24.587% |
| Clearside Biomedical, Inc. | 43 Million USD | -350.143% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -32000.498% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -238.373% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3349.05% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -40121.924% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -584.656% |
| Innoviva, Inc. | 449.07 Million USD | 56.897% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -857.347% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -183.696% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1025.58% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -55.425% |
| Evaxion Biotech A/S | 10.86 Million USD | -1680.789% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -132.124% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -158.408% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -2879.772% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -472012.195% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -617.177% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -41527.097% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -605.698% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1795.29% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -5341.833% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -12347.974% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -15262.381% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1240.114% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -21264.901% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -274.2% |
| ImmunityBio, Inc. | 883.67 Million USD | 78.095% |
| Korro Bio, Inc. | 33.2 Million USD | -482.907% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -172.72% |
| Kineta, Inc. | 1.31 Million USD | -14597.494% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -82454.346% |
| BioVie Inc. | 6.11 Million USD | -3067.27% |
| Codexis, Inc. | 22.36 Million USD | -765.525% |
| Celularity Inc. | 65.41 Million USD | -195.896% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -50439.426% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -86197.815% |
| Kodiak Sciences Inc. | 181.63 Million USD | -6.57% |
| Cibus, Inc. | 24.62 Million USD | -686.183% |
| Annexon, Inc. | 31.35 Million USD | -517.337% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -8164.987% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 86.683% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -157.964% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -4859.416% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -1101.694% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -73.617% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -320.439% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -502.671% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -19551.371% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1589.5% |
| Alkermes plc | 290.73 Million USD | 33.421% |
| Arcellx, Inc. | 97.62 Million USD | -98.275% |
| Moolec Science SA | 2.64 Million USD | -7217.386% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -8907.259% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -2966.149% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -630.08% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -6140.039% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -7958.535% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -11069.417% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -233.126% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -579.489% |
| Geron Corporation | 85.89 Million USD | -125.341% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -325.326% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 96.845% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -167847.316% |
| Notable Labs, Ltd. | 2.04 Million USD | -9346.852% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -472.173% |
| Structure Therapeutics Inc. | 5.45 Million USD | -3449.715% |
| IN8bio, Inc. | 4.89 Million USD | -3855.978% |
| 89bio, Inc. | 27.1 Million USD | -614.055% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -48291.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -260.404% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -7584.24% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -14366.816% |
| Liquidia Corporation | 3.5 Million USD | -5425.721% |
| Mustang Bio, Inc. | 2.49 Million USD | -7648.839% |
| Immunovant, Inc. | 138 Thousand USD | -140165.217% |
| Vericel Corporation | 88.14 Million USD | -119.605% |
| Quantum-Si incorporated | 15.3 Million USD | -1164.889% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -2119.539% |
| XOMA Corporation | 124.45 Million USD | -55.537% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -70544.526% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -236880.901% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1358.014% |
| Vaxcyte, Inc. | 29.22 Million USD | -562.353% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1675.346% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -95252.709% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -836.867% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -11609.982% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -15262.381% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -47931.266% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -18656.395% |
| PepGen Inc. | 20.1 Million USD | -862.823% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -33622.3% |
| United Therapeutics Corporation | 700 Million USD | 72.348% |
| Solid Biosciences Inc. | 26.26 Million USD | -636.973% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -19551.371% |
| Immuneering Corporation | 4.46 Million USD | -4237.167% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -191549.505% |
| Belite Bio, Inc | 886 Thousand USD | -21747.178% |
| Pharming Group N.V. | 171.54 Million USD | -12.837% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 19.219% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -807.44% |
| uniQure N.V. | 138.4 Million USD | -39.851% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1050.125% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -126.597% |
| Altimmune, Inc. | 671 Thousand USD | -28747.392% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1358.014% |
| Peak Bio, Inc. | 10.72 Million USD | -1705.349% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2031.549% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -10979.908% |
| Benitec Biopharma Inc. | 284 Thousand USD | -68057.042% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 56.508% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -66729.166% |
| Compugen Ltd. | 1.35 Million USD | -14227.609% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -91860.15% |
| argenx SE | 20 Million USD | -867.83% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -352.617% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -128.923% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -871.668% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -65.169% |
| PolyPid Ltd. | 11.77 Million USD | -1543.314% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -111.645% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -4529.658% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -32988.205% |
| Instil Bio, Inc. | 86.05 Million USD | -124.936% |
| Elevation Oncology, Inc. | 30.13 Million USD | -542.287% |
| Immunome, Inc. | 1.65 Million USD | -11631.273% |
| Verona Pharma plc | 51.32 Million USD | -277.108% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1879.607% |
| Shattuck Labs, Inc. | 4.2 Million USD | -4506.521% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -53371.271% |
| Design Therapeutics, Inc. | 3.05 Million USD | -6246.426% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -73780.153% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1260.458% |
| Achilles Therapeutics plc | 4.61 Million USD | -4094.28% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 48.206% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -543.098% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -5134.533% |
| Beam Therapeutics Inc. | 173.17 Million USD | -11.776% |
| Moolec Science SA | 2.64 Million USD | -7217.386% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -40650.737% |
| AEON Biopharma, Inc. | 278 Thousand USD | -69528.058% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -2655.78% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -57680.896% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -155.155% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -216.766% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -540.751% |
| Athira Pharma, Inc. | 1.58 Million USD | -12112.366% |
| HCW Biologics Inc. | 6.45 Million USD | -2900.197% |
| XOMA Corporation | 124.45 Million USD | -55.537% |
| NeurAxis, Inc. | 224.26 Thousand USD | -86213.208% |
| Lumos Pharma, Inc. | 6.58 Million USD | -2839.499% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1879.607% |
| 180 Life Sciences Corp. | 1.32 Million USD | -14563.324% |
| Nektar Therapeutics | 230.4 Million USD | 15.987% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -871.668% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1033.282% |
| Arvinas, Inc. | 3.4 Million USD | -5593.118% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -12347.974% |
| Palisade Bio, Inc. | 369 Thousand USD | -52356.911% |
| Nutriband Inc. | 241.28 Thousand USD | -80122.973% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -11762.661% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -23334.14% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -46542.41% |
| Merus N.V. | 12.16 Million USD | -1491.564% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -50.719% |
| Neurogene Inc. | 16.25 Million USD | -1090.809% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 37.183% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -578.203% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1301.231% |
| Rezolute, Inc. | 2.22 Million USD | -8587.882% |
| Clene Inc. | 32.16 Million USD | -501.866% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -110475.654% |
| BeyondSpring Inc. | 3.99 Million USD | -4745.207% |
| Synlogic, Inc. | 17.27 Million USD | -1020.498% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -14789.692% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -552945.714% |
| Peak Bio, Inc. | 10.72 Million USD | -1705.349% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -272.794% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2291.475% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -9.349% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -2642.894% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -141609.006% |
| MannKind Corporation | 382.37 Million USD | 49.378% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1702.626% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -47226.65% |
| Gossamer Bio, Inc. | 212.46 Million USD | 8.895% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -111144.828% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2012.935% |
| Legend Biotech Corporation | 328.67 Million USD | 41.107% |
| Mural Oncology plc | 15 Million USD | -1189.666% |
| Disc Medicine, Inc. | 2.1 Million USD | -9113.041% |
| Champions Oncology, Inc. | 7.43 Million USD | -2505.195% |
| REGENXBIO Inc. | 89.29 Million USD | -116.784% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -22547.324% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -34904.033% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -3475.286% |
| Vaxart, Inc. | 26.51 Million USD | -630.052% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1136.262% |
| Cellectis S.A. | 92.85 Million USD | -108.465% |
| Longeveron Inc. | 2.04 Million USD | -9383.88% |
| Repare Therapeutics Inc. | 3.41 Million USD | -5576.422% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 86.142% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -315.449% |
| Revolution Medicines, Inc. | 87.94 Million USD | -120.101% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -111787.861% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -4796.686% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -60961.83% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -110509.143% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 76.056% |
| Denali Therapeutics Inc. | 52.24 Million USD | -270.525% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1243.699% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -13987.773% |
| Cingulate Inc. | 3.13 Million USD | -6074.159% |
| Passage Bio, Inc. | 26.29 Million USD | -636.16% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -2804.216% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -47342.647% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -21551.678% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -841.423% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -7797.04% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -6098.079% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -23767.571% |
| OmniAb, Inc. | 25.56 Million USD | -657.271% |
| Anew Medical, Inc. | 1.6 Million USD | -11960.187% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -554.318% |
| Lipocine Inc. | 17.16 Thousand USD | -1127512.723% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1563.224% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -458.987% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3176.859% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -238.562% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -95252.709% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -3647.648% |
| Ocugen, Inc. | 6.94 Million USD | -2688.734% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1269.991% |
| Q32 Bio Inc. | 1.31 Million USD | -14586.343% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -28704.464% |
| Alumis Inc. Common Stock | 32.58 Million USD | -494.125% |
| Equillium, Inc. | 824 Thousand USD | -23391.019% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2032.019% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -64249.115% |
| Dominari Holdings Inc. | 3.02 Million USD | -6292.536% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -204759.928% |
| vTv Therapeutics Inc. | 529 Thousand USD | -36490.926% |
| Bio-Techne Corporation | 419.53 Million USD | 53.862% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -168.857% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1046.175% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -750.391% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -3095.213% |
| Nkarta, Inc. | 88.33 Million USD | -119.117% |
| BioCardia, Inc. | 1.31 Million USD | -14619.848% |
| Iterum Therapeutics plc | 19.5 Million USD | -892.188% |